Functional T Cell Assays Are Predictive of Pre-Clinical Potency to Generate Allogeneic, Hypoimmune CD19 CAR T Cells

Darin Salloum(Sana Biotechnology (United States)), Aaron E. Foster(Medpace (United States)), Neal Van Hoeven(Sana Biotechnology (United States)), Jesus Moreno(Sana Biotechnology (United States)), Pascal Beauchesne(Sana Biotechnology (United States)), Ouwen Liang(Sana Biotechnology (United States)), Brian Granger(Sana Biotechnology (United States)), Kavita Tundwal(Sana Biotechnology (United States)), Divy Kangeyan(Sana Biotechnology (United States)), Adam Johnson(Sana Biotechnology (United States)), Terry J. Fry(University of Colorado Anschutz Medical Campus)
Blood
November 15, 2022
Cited by 0


Related Papers